Transplantation of modified human bone marrow-derived stromal cells affords therapeutic effects on cerebral ischemia in rats.

CNS Neurosci Ther · 2022 · PMC9627357 · PMID 36000240

Europe PMC DOI

hedged sentences

0.3120

closest p · 6.2× alpha

0.3120

boldest claim

The sentences

did not reach statistical significancep = 0.312not close (p > 0.1)

In contrast, while there was a trend of increased number of BrdU/Dcx positive cells in the SVZ in SB623 group compared to control and EC groups, but the levels of neurogenesis between groups did not reach statistical significance (vs. control group: p = 0.312; vs.

also in 111,027 other papers

a decreasing trendno p-value reported

On the other hand, while there was also a decreasing trend in cell viability for eSB623, significantly more encapsulated cells remained alive throughout the post‐transplant survival period compared to SB623.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.